Manchester, England, 4 September 2018–Phagenesis Ltd, a pioneering leader in the treatment of dysphagia, is pleased to announce today the publication of its most recent randomised controlled trial (PHAST-TRAC) in the journal Lancet Neurology read more. Reinhard Krickl, CEO of Phagenesis, said: “The … Continue reading
The University of Manchester in collaboration with Salford Royal Hospital is looking for patients from Greater Manchester with confirmed diagnosis of idiopathic Parkinson’s disease and impaired swallowing. They will be offered the possibility to participate in a clinical study that … Continue reading
Pharyngeal Electrical Stimulation Evaluation for Dysphagia after Stroke (PhEED) is a prospective multi-centre randomised controlled single-blinded trial with Non-Significant Risk status granted by FDA. If you are a healthcare professional working in an acute rehab center and are interested in being part … Continue reading
The first results of Pharyngeal Electrical Stimulation for Early Decannulation in Tracheotomised Stroke Patients with Dysphagia (PHAST-TRAC): A Randomised, Single-blind, Pivotal, Superiority Trial were presented by Professor Philip M Bath, University of Nottingham, Nottingham, United Kingdom at International Stroke Conference, Los … Continue reading
